Fotemustine chemoembolization of hepatic metastases from uveal melanoma: A retrospective single-center analysis

American Journal of Roentgenology

Volumn 199, Issue 6, 2012, Pages 1387-1392

  Edelhauser, Gundula ^a   Schicher, Nikolaus ^b   Berzaczy, Dominik ^a   Beitzke, Dietrich ^a   Höeller, Christoph ^b   Lammer, Johannes ^a   Funovics, Martin ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b Universitatsklinik fur Dermatologie   (Austria)

Author keywords

Fotemustine; Liver metastasis; Transarterial chemoembolization; Uveal melanoma

Indexed keywords

ANTIEMETIC AGENT; FOTEMUSTINE; LACTATE DEHYDROGENASE; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE;

ABSCESS; ADULT; AGED; ARTICLE; BLEEDING; CANCER CONTROL; CANCER PROGNOSIS; CANCER SURVIVAL; CHEMOEMBOLIZATION; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; DOSE RESPONSE; DRUG EFFICACY; DRUG FATALITY; DRUG FEVER; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; HUMAN; LACTATE DEHYDROGENASE BLOOD LEVEL; LIVER METASTASIS; LIVER WEIGHT; MALE; MEDICAL RECORD REVIEW; MULTIPLE CYCLE TREATMENT; NAUSEA; POSTEMBOLIZATION SYNDROME; PRIORITY JOURNAL; SURVIVAL RATE; SURVIVAL TIME; SYNDROME; TUMOR VOLUME; UVEA MELANOMA;

ADULT; AGED; ANTINEOPLASTIC AGENTS; CHEMOEMBOLIZATION, THERAPEUTIC; CONTRAST MEDIA; ETHIODIZED OIL; FEMALE; HUMANS; LIVER NEOPLASMS; MALE; MELANOMA; MIDDLE AGED; NITROSOUREA COMPOUNDS; ORGANOPHOSPHORUS COMPOUNDS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; SURVIVAL RATE; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME; UVEAL NEOPLASMS;

EID: 84870860652     PISSN: 0361803X     EISSN: 15463141     Source Type: Journal    
DOI: 10.2214/AJR.11.7748     Document Type: Article

References (32)

1. Wöll E, Bedikian A, Legha SS. Uveal melanoma: natural history and treatment options for metastatic disease. Melanoma Res 1999; 9:575-581 (Pubitemid 30007776)
2. Bedikian AY, Kantarjian H, Young SE. Prognosis in metastatic choroidal melanoma. South Med J 1981; 74:574-577 (Pubitemid 11008824)
3. Leong SP, Gershenwald JE, Soong SJ, et al. Cutaneous melanoma: a model to study cancer metastasis. J Surg Oncol 2011; 103:538-549
4. Jäckel A, Bock M, Deichmann M, Waldmann V, Näher H. Therapy of metastatic malignant uveal melanoma [in German]. Hautarzt 2001; 52:98-103 (Pubitemid 32153749)
5. Seddon JM, Albert DM, Lavin PT, Robinson N. A prognostic factor study of disease-free interval and survival following enucleation for uveal melanoma. Arch Ophthalmol 1983; 101:1894-1899 (Pubitemid 14249570)
6. Gragoudas ES, Egan KM, Seddon JM. Survival of patients with metastases from uveal melanoma. Ophthalmology 1991; 98:383-389; discussion, 390
7. Rajpal S, Moore S, Karakousis CP. Survival in metastatic ocular melanoma. Cancer 1983; 52:334-336 (Pubitemid 13063179)
8. Kath R, Hayungs J, Bornfeld N, Sauerwein W, Höffken K, Seeber S. Prognosis and treatment of disseminated uveal melanoma. Cancer 1993; 72: 2219-2232
9. Peters S, Voelter V, Zografos L, et al. Intra-arterial hepatic fotemustine for the treatment of liver metastases from uveal melanoma: experience in 101 patients. Ann Oncol 2006; 17:578-583
10. Pyrhönen S, Hahka-Kemppinen M, Muhonen T, et al. Chemoimmunotherapy with bleomycin, vincristine, lomustine, dacarbazine (BOLD), and human leucocyte interferon for metastatic uveal melanoma. Cancer 2002; 95:2366-2372 (Pubitemid 35351144)
11. Nathan FE, Berd D, Sato T, et al. BOLD + interferon in treatment of metastatic uveal melanoma: first report of active systemic therapy. J Exp Clin Cancer Res 1997; 16:201-208 (Pubitemid 27376581)
12. Kivelä T, Suciu S, Hansson J, et al. Bleomycin, vincristine, lomustine and dacarbazine (BOLD) in combination with recombinant interferon alpha-2b for metastatic uveal melanoma. Eur J Cancer 2003; 39:1115-1120 (Pubitemid 36555869)
13. Avril MF, Aamdal S, Grob JJ, et al. Fotemustine compared with dacarbazine in patients with disseminated malignant melanoma: a phase III study. J Clin Oncol 2004; 22:1118-1125 (Pubitemid 41095046)
14. Albert DM, Niffenegger AS, Willson JKV. Treatment of metastatic uveal melanoma: review and recommendations. Surv Ophthalmol 1992; 36:429-438
15. Fety R, Lucas C, Solere P, et al. Hepatic intra-arterial infusion of fotemustine: pharmacokinetics. Cancer Chemother Pharmacol 1992; 31:118-122
16. Collins JM. Pharmacologic rationale for hepatic arterial therapy. Recent Results Cancer Res 1986; 100:140-147
17. Leyvraz S, Spataro V, Bauer J, et al. Treatment of ocular melanoma metastatic to the liver by hepatic arterial chemotherapy. J Clin Oncol 1997; 15:2589-2595 (Pubitemid 27289889)
18. Schuster R, Lindner M, Wacker F, et al. Transarterial chemoembolization of liver metastases from uveal melanoma after failure of systemic therapy: toxicity and outcome. Melanoma Res 2010; 20:191-196
19. Takayasu K, Arii S, Ikai I, et al.; Liver Cancer Study Group of Japan. Overall survival after transarterial Lipiodol infusion chemotherapy with or without embolization for unresectable hepatocellular carcinoma: propensity score analysis. AJR 2010; 194:830-837
20. Fukumori K, Yano Y, Ando E, et al. Transarterial chemoembolization as salvage therapy after unsuccessful hepatic arterial infusion chemotherapy in advanced hepatocellular carcinoma. Mol Med Report 2008; 1:521-524
21. Bedikian AY, Legha SS, Mavligit G, et al. Treatment of uveal melanoma metastatic to the liver. Cancer 1995; 76:1665-1670
22. Brasiuniene B, Sokolovas V, Brasiunas V, Barakauskiene A, Strupas K. Combined treatment of uveal melanoma liver metastases. Eur J Med Res 2011; 16:71-75
23. Cantore M, Fiorentini G, Aitini E, et al. Intra-arterial hepatic carboplatin-based chemotherapy for ocular melanoma metastatic to the liver: report of a phase II study. Tumori 1994; 80:37-39 (Pubitemid 24161620)
24. Huppert PE, Fierlbeck G, Pereira P, et al. Transarterial chemoembolization of liver metastases in patients with uveal melanoma. Eur J Radiol 2009 May 21 [Epub ahead of print];
25. Eur J Radiol 2010; 74:e38-e44
26. Patel K, Sullivan K, Berd D, et al. Chemoembolization of the hepatic artery with BCNU for metastatic uveal melanoma: results of a phase II study. Melanoma Res 2005; 15:297-304 (Pubitemid 41127467)
27. Vogl T, Eichler K, Zangos S, et al. Preliminary experience with transarterial chemoembolization (TACE) in liver metastases of uveal malignant melanoma: local tumor control and survival. J Cancer Res Clin Oncol 2007; 133:177-184 (Pubitemid 46144093)
28. Gonsalves CF, Eschelman DJ, Sullivan KL, Anne PR, Doyle L, Sato T. Radioembolization as salvage therapy for hepatic metastasis of uveal melanoma: a single-institution experience. AJR 2011; 196:468-473
29. Carrasco CH, Wallace S, Charnsangavej C, Papadopoulos NE, Patt YZ, Mavligit GM. Treatment of hepatic metastases in ocular melanoma: embolization of the hepatic artery with polyvinyl sponge and cisplatin. JAMA 1986; 255:3152-3154 (Pubitemid 16095332)
30. Mavligit GM, Charnsangavej C, Carrasco H, Patt YZ, Benjamin RS, Wallace S. Regression of ocular melanoma metastatic to the liver after hepatic arterial chemoembolization with cisplatin and polyvinyl sponge. JAMA 1988; 260:974-976
31. Feun LG, Reddy KR, Yrizarry JM, et al. A phase I study of chemoembolization with cisplatin and Lipiodol for primary and metastatic liver cancer. Am J Clin Oncol 1994; 17:405-410 (Pubitemid 24298945)
32. Agarwala SS, Panikkar R, Kirkwood JM. Phase I/II randomized trial of intrahepatic arterial infusion chemotherapy with cisplatin and chemoembolization with cisplatin and polyvinyl sponge in patients with ocular melanoma metastatic to the liver. Melanoma Res 2004; 14:217-222 (Pubitemid 38879585)